Continuation of anticoagulant and antiplatelet therapy during phacoemulsification cataract surgery

Current Opinion in Ophthalmology

Volumn 26, Issue 1, 2015, Pages 28-33

  Grzybowski, Andrzej ^a,b   Ascaso, Francisco J ^c,d   Kupidura Majewski, Konrad ^b   Packer, Mark ^e  

^a Poznan City Hospital   (Poland)

^b UNIVERSITY OF WARMIA AND MAZURY IN OLSZTYN   (Poland)

^c Lozano Blesa University Clinical Hospital   (Spain)

^d INSTITUTO ARAGONÉS DE CIENCIAS DE LA SALUD   (Spain)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Anticoagulants in ocular surgery; Cataract surgery complications; Ocular surgery complications

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; WARFARIN;

ANTICOAGULANT THERAPY; CATARACT; CHOROID HEMORRHAGE; DRUG WITHDRAWAL; ELECTIVE SURGERY; HIGH RISK PATIENT; HUMAN; HYPHEMA; INTRAOCULAR HEMORRHAGE; LENS IMPLANTATION; MAINTENANCE THERAPY; PEROPERATIVE COMPLICATION; PHACOEMULSIFICATION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PRACTICE GUIDELINE; RETINA HEMORRHAGE; RETROBULBAR HEMORRHAGE; REVIEW; SUBCONJUNCTIVAL HEMORRHAGE; SURGICAL RISK; SYSTEMATIC REVIEW; THROMBOEMBOLISM; TOPICAL ANESTHESIA; TREATMENT INDICATION; TREATMENT WITHDRAWAL; VITREOUS HEMORRHAGE; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; HUMANS; INTRAOPERATIVE COMPLICATIONS; LENS IMPLANTATION, INTRAOCULAR; PHACOEMULSIFICATION; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE COMPLICATIONS; VENOUS THROMBOEMBOLISM;

EID: 84916934078     PISSN: 10408738     EISSN: 15317021     Source Type: Journal    
DOI: 10.1097/ICU.0000000000000117     Document Type: Review

References (41)

1. García DA, Witt DM, Hylek E, et al. Delivery of optimized anticoagulant therapy: Consensus statement from the Anticoagulation Forum. Ann Pharmacother 2008; 42: 979-988.
2. Gaines KK. Management of anticoagulation therapy for invasive procedures. Urol Nurs 2005; 25: 379-380.
3. Douketis JD. Perioperative anticoagulation management in patients who are receiving oral anticoagulant therapy: A practical guide for clinicians. Thromb Res 2002; 108: 3-13.
4. Douketis JD, Berger PB, Dunn AS, et al. The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133 (Suppl 6): 299S-339S.
5. Hodge W, Horsley T, Albiani D, et al. The consequences of waiting for cataract surgery: A systematic review. Can Med Assoc J 2007; 176: 1285-1290.
6. Konstantatos A. Anticoagulation and cataract surgery: A review of the current literature. Anaesth Intensive Care 2001; 29: 11-18.
7. Dunn AS, Turpie AGG. Perioperative management of patients receiving oral anticoagulants: A systematic review. Arch Intern Med 2003; 163: 901-908.
8. Broderick JP, Bonomo JB, Kissela BM, et al. Withdrawal of antithrombotic agents and its impact on ischemic stroke occurrence. Stroke 2011; 42: 2509-2514.
9. Robinson M, Healey JS, Eikelboom J, et al. Postoperative low-molecularweight heparin bridging is associated with an increase in wound hematoma following surgery for pacemakers and implantable defibrillators. Pacing Clin Electrophysiol 2009; 32: 378-382.
10. Stone LS, Kline OR Jr, Sklar C. Intraocular lenses and anticoagulation and antiplatelet therapy. J Am Intraocul Implant Soc 1985; 11: 165-168.
11. Ong-Tone L, Paluck EC, Hart-Mitchell RD. Perioperative use of warfarin and aspirin in cataract surgery by Canadian Society of Cataract and Refractive surgery members: Survey. J Cataract Refract Surg 2005; 31: 991-996.
12. Barequet IS, Sachs D, Priel A, et al. Phacoemulsification of cataract in patients receiving Coumadin therapy: Ocular and hematologic risk assessment. Am J Ophthalmol 2007; 144: 719-723.
13. Barequet IS, Sachs D, Shenkman B, et al. Risk assessment of simple phacoemulsification in patients on combined anticoagulant and antiplatelet therapy. J Cataract Refract Surgery 2011; 37: 1434-1438.
14. Salam T, Raines MF. Clopidogrel and intraocular surgery: Complicated or uncomplicated? Grand Rounds 2007; 7: 58-60.
15. Moher D, Cook DJ, Eastwood S, et al. Improving the quality of reports of metaanalyses of randomised controlled trials: The QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 1999; 354: 1896-1900.
16. Heinze G, Schemper M. A solution to the problem of separation in logistic regression. Stat Med 2002; 21: 2409-2419.
17. Benzimira JD, Johnston RL, Jaycock P, et al. EPR User Group. The Cataract National Dataset electronic multicentre audit of 55 567 operations: Antiplatelet and anticoagulant medications. Eye (Lond) 2009; 23: 10-16.
18. Kobayashi H. Evaluation of the need to discontinue antiplatelet and anticoagulant medications before cataract surgery. J Cataract Refract Surg 2010; 36: 1115-1119.
19. Katz J, Feldman MA, Bass EB, et al., Study of Medical Testing for Cataract Surgery Team. Risks and benefits of anticoagulant and antiplatelet medication use before cataract surgery. Ophthalmology 2003; 110: 1784-1788.
20. Kallio H, Paloheimo M, Maunuksela EL. Haemorrhage and risk factors associated with retrobulbar/peribulbar block: A prospective study in 1383 patients. Br J Anaesth 2000; 85: 708-711.
21. Assia EI, Raskin T, Kaiserman I, et al. Effect of aspirin intake on bleeding during cataract surgery. J Cataract Refract Surg 1998; 24: 1243-1246.
22. Carter K, Miller KM. Phacoemulsification and lens implantation in patients treated with aspirin or warfarin. J Cataract Refract Surg 1998; 24: 1361-1364.
23. Gainey SP, Robertson DM, Fay W, Ilstrup D. Ocular surgery on patients receiving long-term warfarin therapy. Am J Ophthalmol 1989; 108: 142-146.
24. Hall DL, Steen WHJr, Drummond JW, Byrd WA. Anticoagulants and cataract surgery. Ophthalmic Surg 1988; 19: 221-222.
25. McCormack P, Simcock PR, Tullo AB. Management of the anticoagulated patient for ophthalmic surgery. Eye 1993; 7: 749-750.
26. Robinson GA, Nylander A. Warfarin cataract extraction. Br J Ophthalmol 1989; 73: 702-703.
27. Kumar N, Jivan S, Pulpa V, McLure H. Sub-Tenon's anesthesia with aspirin, warfarin, and clopidogrel. J Cataract Refract Surg 2006; 32: 1022-1025.
28. American Academy of Ophthalmology. Cataract in the adult eye PPP, 2011. http://one.aao.org/preferred-practice-pattern/cataract-in-adult-eye-ppp-octo ber-2011. (Accessed 16 April 2014)
29. The Royal College of Ophthalmologists. Cataract Surgery Guidelines. London, UK, Royal College of Ophthalmologists, 2004; updated 2010. www.rcophth.ac.uk/core/core-picker/download.asp?id=544&filetitle=Cata ract+Surgery+Guidelines+2010 (Accessed 16 April 2014)
30. Batra R, Maino A, Chang SW, Marsh IB. Perioperative management of anticoagulated patients having cataract surgery: National audit of current practice of members of the Royal College of Ophthalmologists. J Cataract Refract Surg 2009; 35: 1815-1820.
31. Canadian Journal of Ophthalmology. Canadian Ophthalmological Society evidence-based clinical practice guidelines for cataract surgery in the adult eye, 2008. www.supereyecare.com/residents/COSCataractGuidelines.pdf.
32. The International Council of Ophthalmology. ICO International Clinical Guidelines, Cataract (Initial and follow-up evaluation), 2011. http://www.icoph.org/(Accessed 16 April 2014)
33. Baron TH, Kamath PS, McBane RD. Management of antithrombotic therapy in patients undergoing invasive procedures. N Engl J Med 2013; 368: 2113-2124.
34. Grzybowski A, Ascaso FJ. Antithrombotic therapy and invasive procedures. N Engl J Med 2013; 369: 1079.
35. Jamula E, Anderson J, Douketis JD. Safety of continuing warfarin therapy during cataract surgery: A systematic review and meta-analysis. Thromb Res 2009; 124: 292-299.
36. Jonas JB, Pakdman B, Sauder G. Cataract surgery under systemic anticoagulant therapy with coumarin. Eur J Ophthalmol 2006; 16: 30-32.
37. Hall DL. Cataract surgery and anticoagulants. J La State Med Soc 1996; 148: 431-433.
38. McMahan LB. Anticoagulants and cataract surgery. J Cataract Refract Surg 1988; 14: 569-571.
39. Wirbelauer C, Weller A, Haberle H, Pham DT. Kataraktoperation in topischer anasthesie unter oraler anticoagulation. [Cataract surgery under topical anesthesia with oral anticoagulants.] Klin Monatsbl Augenheilkd 2004; 221: 749-752.
40. Heit JA. Perioperative management of the chronically anticoagulated patient. J Thromb Thrombolysis 2001; 12: 80-87.
41. Kiire CA, Mukherjee R, Ruparella N, et al. Managaing antiplatelet and anticoagulant drugs in patients undergoing elective ophthalmic surgery. Br J Ophthalmol 2014; 98: 1320-1324.